Clinical Trials Logo

Osteoarthritis, Knee clinical trials

View clinical trials related to Osteoarthritis, Knee.

Filter by:

NCT ID: NCT02915120 Recruiting - Clinical trials for Osteoarthritis, Knee

Ultrasound-Guided Pulsed Radiofrequency In The Treatment Of Patients With Osteoarthritis Knee (USPRFGENOAK)

USPRFGENOAK
Start date: March 27, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if patients with chronic painful knee osteoarthritis experience meaningful and long-term improvement in pain, function, and analgesic use after ultrasound-guided pulsed radiofrequency of the genicular nerves following a double diagnostic genicular nerve blocks.

NCT ID: NCT02913521 Completed - Clinical trials for Osteoarthritis, Knee

Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1%

Start date: June 2015
Phase: Phase 3
Study type: Interventional

A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Three-Arm, Multi-Site Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Topical Gel 1% (Hi-Tech Pharmacal Co., Inc.) With Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis) in Patients With Osteoarthritis of the Knee

NCT ID: NCT02910570 Completed - Clinical trials for Osteoarthritis, Knee

Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis

Start date: November 2016
Phase: Phase 4
Study type: Interventional

This is sub-study to a randomised, double blind, placebo-controlled, parallel group, and single-centre trial investigating the effect of liraglutide on body weight and pain in overweight or obese patients with knee osteoarthritis (NCT02905864). In the parent trial patients will be subjected to a run-in diet intervention phase (week -8 to 0) including a low-calorie diet and dietetic counselling. At week 0 patients will be randomised to receive either liraglutide 3 mg or liraglutide 3 mg placebo as an add-on to dietetic guidance on re-introducing regular foods and a focus on continued motivation to engage in a healthy lifestyle. This sub-study of the parent trial only involves an additional assessment of skin auto fluorescence (AGE concentration) in the preallocation phase and in the main trial phase, i.e. from enrollment (defined as signature of informed consent) to treatment allocation (visits -Tx and T0 in the parent trial visit schedule) and from allocation to end of trial (visits T0 and T15 in the parent trial visit schedule).

NCT ID: NCT02910544 Completed - Clinical trials for Osteoarthritis, Knee

Weight Loss and Physical Activity in Overweight/Obese Individuals With Knee Osteoarthritis

Start date: November 2016
Phase:
Study type: Observational

This is a substudy to a randomised trial investigating the effect of liraglutide on body weight and pain in overweight or obese patients with knee osteoarthritis (NCT02905864). In the parent trial, patients will be subjected to an 8-week diet intervention phase including a low-calorie diet and dietetic counselling, after which.they will be randomised to receive either liraglutide 3 mg or liraglutide 3 mg placebo as an add-on to dietetic guidance on re-introducing regular foods and a focus on continued motivation to engage in a healthy lifestyle. This substudy aims to investigate any changes in physical activity associated with the initial 8-week weight loss intervention.

NCT ID: NCT02909257 Terminated - Clinical trials for Osteoarthritis, Knee

Motor-Sparing Femoral Nerve Block Dose

Start date: September 2016
Phase: Phase 4
Study type: Interventional

Femoral nerve blocks are commonly used to provide pain control for total knee replacement, anterior cruciate ligament (ACL) reconstruction. Commonly employed local anesthetic concentrations result in motor block of the quadriceps and constitute an inherent risk factor for patient fall. The aim of this study is to determine the minimum effective concentration of bupivacaine in 90 % of patients (MEC90) required for a motor-sparing, successful sensory block of the femoral nerve.

NCT ID: NCT02905864 Completed - Obesity Clinical Trials

Liraglutide 3 mg for Knee Osteoarthritis

LOSEIT
Start date: November 2016
Phase: Phase 4
Study type: Interventional

A randomised, double blind, placebo-controlled, parallel group, and single-centre trial investigating the effect of liraglutide on body weight and pain in overweight or obese patients with knee osteoarthritis. Patients will be subjected to a run-in diet intervention phase (week -8 to 0) including a low-calorie diet and dietetic counselling. At week 0 patients will be randomised to receive either liraglutide 3 mg or liraglutide 3 mg placebo as an add-on to dietetic guidance on re-introducing regular foods and a focus on continued motivation to engage in a healthy lifestyle.

NCT ID: NCT02905799 Completed - Knee Osteoarthritis Clinical Trials

Resveratrol in Knee Osteoarthritis

ARTHROL
Start date: November 9, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether resveratrol is effective in the treatment of painful knee osteoarthritis.

NCT ID: NCT02905747 Completed - Clinical trials for Osteoarthritis, Knee

The Effect of Medical Exercise Therapy on Pain, Function and Physical Activity in Patients With Knee Osteoarthritis

Start date: September 2016
Phase: N/A
Study type: Interventional

The aim of the project is to investigate effects of medical exercise therapy (MET) on patients with knee osteoarthritis. MET is a common physical therapy intervention, and the project aim to strengthen the evidence of this intervention. An experimental cohort design is chosen, and 20 participants will be followed for 6 months. Assessments will be clinical tests, questionnaires and accelerometer measurements before, during, and after a 3 month period of exercise (3 days per week) with a physical therapist. The project will answer if a 3 month physical therapy intervention using MET causes changes in pain level, function and activity level for patients with knee osteoarthritis. In addition, it will investigate whether a single global endurance workout for 30 minutes will have an effect on pain level for these patients

NCT ID: NCT02905240 Completed - Osteoarthritis Clinical Trials

Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis

PROGRESS IV
Start date: November 2016
Phase: N/A
Study type: Interventional

A double-blind, multicenter, randomized, controlled trial (RCT) that will evaluate the efficacy of a single dose of Autologous Protein Solution (APS) in patients with Osteoarthritis (OA) of the knee.

NCT ID: NCT02904785 Recruiting - Clinical trials for Unilateral Primary Osteoarthritis of Knee

Extracorporeal Focused Shock Wave Therapy for Primary Knee Osteoarthritis

Start date: May 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Extracorporeal Focused Shock Wave Therapy reduces knee pain and enhance function in patients with primary knee osteoarthritis.